TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Pomalidomide is active in the treatment of anemia associated with myelofibrosis.

Ayalew Tefferi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.